Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.1905 per EA under NDC 13107021205. Its NADAC has been published 343 times since Dec 4, 2019.

HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.1905per EA
DEA Schedule CII

Strength

300; 7.5 mg/1; mg/1

NDC

13107021205

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207709

On Market Since

5/6/2015

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has been published 343 times since Dec 4, 2019, and over the history we have for it it has declined 11.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1905 per EA
All-time high$0.6564 (Jun 10, 2020)
All-time low$0.1542 (Jul 17, 2024)
52-week high$0.2478
52-week low$0.1719
Median price$0.2504
Average price$0.2944
Largest weekly change+89.2% (Apr 22, 2020)
Weeks tracked343
Tracking sinceDec 4, 2019

Price History

1W

0.0%

1M

-0.3%

3M

+6.2%

6M

+8.6%

1Y

-21.3%

3Y

-56.5%

5Y

-36.8%

All

-11.8%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.1905 per EA (NDC 13107021205), effective Jun 24, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has declined 11.8%. It has been tracked across 343 weekly CMS publications since Dec 4, 2019.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

Since Dec 4, 2019, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has ranged from a low of $0.1542 (Jul 17, 2024) to a high of $0.6564 (Jun 10, 2020), with a median of $0.2504 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET, is $0.1741 per EA — about 9% below HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET (NDC 13107021205) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.